Reproductive Medicine
A topic in the Science corpus, drawn from 1,053 papers.
Trusted voices in Reproductive Medicine
Ordered by the trust Reproductive Medicine's own network concentrates on each researcher, most first.
- R. Buchholz — trusted by 67 researchers here
- G. Herek — trusted by 33 researchers here
- A. D’augelli — trusted by 20 researchers here
- L. Kurdek — trusted by 23 researchers here
- C. Patterson — trusted by 16 researchers here
- Philip Ball — trusted by 12 researchers here
- Markus P. Bidell — trusted by 9 researchers here
- W. Fabricius — trusted by 10 researchers here
- Ç. Gerçel-Taylor — trusted by 14 researchers here
- D. Taylor — trusted by 14 researchers here
- F. Marlowe — trusted by 11 researchers here
- Amy L. Hequembourg — trusted by 8 researchers here
Most-cited papers in Reproductive Medicine
Ordered by the recorded citation count from the source corpus; a citation is not an endorsement.
- Publisher's Note (2003) — 287,289 citations
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). (2004, Human Reproduction) — 8,538 citations
- Integrated Genomic Analyses of Ovarian Carcinoma (2011, Nature) — 7,559 citations
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. (2004, Fertility and Sterility) — 5,680 citations
- Integrated Genomic Characterization of Endometrial Carcinoma (2013, Nature) — 5,292 citations
- An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction (2010, International Urogynecology Journal) — 4,842 citations
- Polycystic ovary syndrome (2016, Nature Reviews Disease Primers) — 4,774 citations
- Publisher's Note (2017, Neuroscience and Biobehavioral Reviews) — 4,705 citations
- Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. (2003, American Journal of Human Genetics) — 3,796 citations
- The need for a new medical model: a challenge for biomedicine. (2012, Psychodynamic Psychiatry) — 3,787 citations
- Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects (2009, Journal of the Indian Medical Association) — 3,694 citations
- Elective single-embryo transfer versus double-embryo transfer in in vitro fertilization (2004, New England Journal of Medicine) — 3,665 citations
- Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. (2009, New England Journal of Medicine) — 3,580 citations
- Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. (2003, New England Journal of Medicine) — 3,391 citations
- Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7 (2012) — 3,084 citations
- Ovarian Cancer Statistics, 2018 (2018, Ca) — 3,060 citations
- The oxytocin receptor system: structure, function, and regulation. (2001, Physiological Reviews) — 2,972 citations
- The Health of Lesbian, Gay, Bisexual, and Transgender People: Building a Foundation for Better Understanding (2011) — 2,758 citations
- World Health Organization reference values for human semen characteristics. (2010, Human Reproduction Update) — 2,683 citations
- Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome (2018, Clinical Endocrinology) — 2,461 citations
- Prolactin: structure, function, and regulation of secretion. (2000, Physiological Reviews) — 2,429 citations
- International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. (2007, Human Reproduction) — 2,406 citations
- Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium (2009) — 2,389 citations
- Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer (2018, New England Journal of Medicine) — 2,381 citations
- Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. (2010, New England Journal of Medicine) — 2,377 citations
- MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. (2008, Gynecologic Oncology) — 2,343 citations
- High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. (2003, American Journal of Obstetrics and Gynecology) — 2,316 citations
- Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54 (2003, Proceedings of the National Academy of Sciences of the United States of America) — 2,310 citations
- Incorporation of bevacizumab in the primary treatment of ovarian cancer. (2011, New England Journal of Medicine) — 2,288 citations
- Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging (2012, Menopause) — 2,286 citations
- Nature Communications (2010) — 2,248 citations
- Men at risk: occupation and male infertility. (2004, Fertility and Sterility) — 2,209 citations
- Supplemental digital content. (2013, Health Physics) — 2,192 citations
- National, Regional, and Global Trends in Infertility Prevalence Since 1990: A Systematic Analysis of 277 Health Surveys (2012, PLoS Medicine) — 2,158 citations
- A unique view on male infertility around the globe (2015, Reproductive Biology and Endocrinology) — 2,134 citations
- Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer. (2016, New England Journal of Medicine) — 2,122 citations
- Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2 (2003, Science) — 2,115 citations
- Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. (2002, Journal of Clinical Oncology) — 2,079 citations
- Climate of change. (2008, Nursing Standard) — 2,068 citations
- Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. (2003, Journal of Clinical Oncology) — 2,032 citations
- The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. (2009, Fertility and Sterility) — 2,022 citations
- A phase 3 trial of bevacizumab in ovarian cancer. (2011, New England Journal of Medicine) — 2,021 citations
- ESHRE guideline: management of women with endometriosis. (2014, Human Reproduction) — 1,979 citations
- A conceptual framework for clinical work with transgender and gender nonconforming clients: An adaptation of the Minority Stress Model. (2012) — 1,960 citations
- American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. (2006, Journal of Clinical Oncology) — 1,955 citations
- Fertility and infertility: Definition and epidemiology. (2018, Clinical Biochemistry) — 1,940 citations
- Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. (2006, Journal of Clinical Endocrinology and Metabolism) — 1,909 citations
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial. (2010, The Lancet) — 1,894 citations
- The Origin and Pathogenesis of Epithelial Ovarian Cancer- a Proposed Unifying Theory (2010, American Journal of Surgical Pathology) — 1,864 citations
- The complex role of estrogens in inflammation. (2007, Endocrine reviews) — 1,859 citations
Most active researchers
By papers in this topic: a volume measure, not trust.
- Bart C. J. M. Fauser — 13 papers
- Jonathan A. Ledermann — 13 papers
- R. Legro — 13 papers
- R. Norman — 11 papers
- A. Oza — 11 papers
- R. Azziz — 11 papers
- Ie-Ming Shih — 9 papers
- N. Colombo — 9 papers
- M. Mirza — 9 papers
- J. Laven — 8 papers
- Didier Dewailly — 8 papers
- A. Agarwal — 8 papers